Miles Gerson is a highly experienced investment director specializing in the life sciences industry. He is currently a Senior Investment Director and Partner at Takeda Ventures, Inc. With an educational background in both law and business, Miles has developed expertise in strategic planning, corporate governance, and business development. His experience working in venture capital firms, development groups, and bio-businesses has helped him develop a unique approach to investment management.

Miles' experience extends across several companies, including Catamaran Bio, Transine Therapeutics, Carmine Therapeutics, and IMMPACT BIO USA INC. His previous positions include Board Observer at Carmine Therapeutics, Partner at Takeda Ventures, Inc., Managing Officer of Business Development at UCLA Technology Development Group, and Venture Capital Analyst at High Country Venture. His skills also include legal counseling, project management, and corporate finance.

Miles Gerson earned his JD and MBA from the University of Wisconsin-Madison and studied at the Copenhagen Business School. He also completed a Master's degree and a Bachelor's degree at Wesleyan University. Additionally, he has served as the Director of Finance and Administration; Corporate Secretary at TriSalus Life Sciences and Executive Director at Diabetes Sports and Wellness Foundation.